Global contract manufacturing organization (CMO) Symbiosis Pharmaceutical Services has successfully completed the latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland. Headquartered in Stirling, UK, and specializing in the sterile manufacture of pharmaceuticals and biopharmaceuticals for clinical trials and the supply of commercial markets, Symbiosis recorded zero GMP observations from the FDA during the inspection in January 2025. The FDA inspection...